996 Combination therapy of peginterferon alfa-2A (40KD) (PEGASYS(R)) and ribavirin (COPEGUS(R)) significantly enhance sustained virological and biochemical response rate in chronic hepatitis C genotype 4 patients in Saudi Arabia

Ossama A. Shobokshi, Frank E. Serebour, Leila Skakni, A Tantawi, Ali Metalli -Sabah, Thotapara Dinish, Mohammed Alquaiz, Khawla Al Qahtani, Abdulkareem Sandokji

Hepatology · 2003 · 28 citations · 0 references

Concepts